Tau PET imaging can distinguish PSP’s subcortical tau deposition from the cortical pathology typical of AD, but this distinction diminishes when compared with other 4R tauopathies like CBD, which share similar anatomical distributions and binding profiles [162]. The gene discussed is MAPT; the disease is tauopathy.